1. Home
  2. GPRO vs VRCA Comparison

GPRO vs VRCA Comparison

Compare GPRO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

HOLD

Current Price

$0.78

Market Cap

154.6M

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.03

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRO
VRCA
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.6M
137.3M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
GPRO
VRCA
Price
$0.78
$6.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
6.9M
46.5K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
79.08
N/A
EPS
N/A
N/A
Revenue
$651,542,000.00
$35,577,000.00
Revenue This Year
$23.14
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$0.59
$0.52
52 Week High
$3.05
$9.82

Technical Indicators

Market Signals
Indicator
GPRO
VRCA
Relative Strength Index (RSI) 32.19 48.00
Support Level $0.74 $5.27
Resistance Level $1.88 $6.40
Average True Range (ATR) 0.10 0.52
MACD -0.04 -0.00
Stochastic Oscillator 2.36 43.37

Price Performance

Historical Comparison
GPRO
VRCA

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: